Qualigen Therapeutics, Inc. announced that it has appointed Shishir Sinha, the company's newly promoted Senior Vice President and current Chief Operating Officer, to lead the company's diagnostics division.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2024 USD | +3.40% | -25.04% | -63.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.20% | 1.28M | |
+49.21% | 56.87B | |
+35.03% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President